MORPHINE SULFATE INJECTION

The Defense Logistics Agency (DLA) awarded a delivery order under the basic contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the purchase of one package of Morphine Sulfate Injection (NSN 6505014830274) at a total price of $42.99, with an award date of July 16, 2026. The delivery is FOB destination, with the contractor responsible for all transportation costs and risks until the item is received at USNS LEROY GRUMMAN T AO 195, Unit 100371 Box 1, FPO AE 09570, USA. The product must be shipped by the fastest traceable means, excluding parcel post, and will be inspected and accepted by the government upon arrival. The awardee is certified as a small business, small disadvantaged business, and women-owned business, triggering federal reporting obligations under FAR 19.3, FAR 19.5, and FAR 19.15. Invoicing must comply with DFARS 252.232-7003, which requires electronic submission through the Wide Area WorkFlow system, and payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, under payment code SL4701 with net 30-day terms. The accounting identifier 97X4930 5CBX 001 2620 S33189 is used for fund allocation, and the contracting officer is Lisa Quinn, with administrative support provided by Shairy M. Cartagena. No additional line items, options, or special requirements beyond shipment, invoicing, and acceptance are specified in the available documentation, and no formal packaging standards or quality control specifications beyond contract conformity are cited. The order reflects a minimal dollar-value transaction likely executed under a low-price, technically acceptable procurement methodology under an IDIQ vehicle.